JP2003531811A5 - - Google Patents

Download PDF

Info

Publication number
JP2003531811A5
JP2003531811A5 JP2000603378A JP2000603378A JP2003531811A5 JP 2003531811 A5 JP2003531811 A5 JP 2003531811A5 JP 2000603378 A JP2000603378 A JP 2000603378A JP 2000603378 A JP2000603378 A JP 2000603378A JP 2003531811 A5 JP2003531811 A5 JP 2003531811A5
Authority
JP
Japan
Prior art keywords
acid sequence
polypeptide
nucleic acid
amino acid
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000603378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003531811A (ja
Filing date
Publication date
Priority claimed from PCT/US1999/005028 external-priority patent/WO1999046281A2/en
Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en
Priority claimed from PCT/US1999/020111 external-priority patent/WO2000012708A2/en
Priority claimed from PCT/US1999/021090 external-priority patent/WO2000015796A2/en
Priority claimed from PCT/US1999/028313 external-priority patent/WO2000032221A2/en
Priority claimed from PCT/US1999/028409 external-priority patent/WO2000032778A2/en
Priority claimed from PCT/US1999/028565 external-priority patent/WO2000037638A2/en
Priority claimed from PCT/US2000/000219 external-priority patent/WO2000053753A2/en
Priority claimed from PCT/US2000/004341 external-priority patent/WO2000053756A2/en
Priority claimed from PCT/US2000/004342 external-priority patent/WO2000078961A1/en
Priority claimed from PCT/US2000/004414 external-priority patent/WO2001004311A1/en
Application filed filed Critical
Priority claimed from PCT/US2000/005004 external-priority patent/WO2000053757A2/en
Publication of JP2003531811A publication Critical patent/JP2003531811A/ja
Publication of JP2003531811A5 publication Critical patent/JP2003531811A5/ja
Pending legal-status Critical Current

Links

Images

JP2000603378A 1999-03-08 2000-02-24 血管形成及び心臓血管新生の促進又は阻害 Pending JP2003531811A (ja)

Applications Claiming Priority (29)

Application Number Priority Date Filing Date Title
PCT/US1999/005028 WO1999046281A2 (en) 1998-03-10 1999-03-08 Novel polypeptides and nucleic acids encoding the same
US9905028 1999-03-08
US12395799P 1999-03-12 1999-03-12
US60/123,957 1999-03-12
US9912252 1999-06-02
PCT/US1999/012252 WO1999063088A2 (en) 1998-06-02 1999-06-02 Membrane-bound proteins and nucleic acids encoding the same
US14475899P 1999-07-20 1999-07-20
US60/144,758 1999-07-20
US14569899P 1999-07-26 1999-07-26
US60/145,698 1999-07-26
PCT/US1999/020111 WO2000012708A2 (en) 1998-09-01 1999-09-01 Further pro polypeptides and sequences thereof
US9920111 1999-09-01
PCT/US1999/021090 WO2000015796A2 (en) 1998-09-16 1999-09-15 Secreted and transmembrane polypeptides and nucleic acids encoding the same
US9921090 1999-09-15
US9928313 1999-11-30
PCT/US1999/028409 WO2000032778A2 (en) 1998-12-01 1999-11-30 Methods and compositions for inhibiting neoplastic cell growth
US9928409 1999-11-30
PCT/US1999/028313 WO2000032221A2 (en) 1998-12-01 1999-11-30 Promotion or inhibition of angiogenesis and cardiovascularization
US9928565 1999-12-02
PCT/US1999/028565 WO2000037638A2 (en) 1998-12-22 1999-12-02 Methods and compositions for inhibiting neoplastic cell growth
US0000219 2000-01-05
PCT/US2000/000219 WO2000053753A2 (en) 1999-03-08 2000-01-05 Promotion or inhibition of angiogenesis and cardiovascularization
PCT/US2000/004341 WO2000053756A2 (en) 1999-03-08 2000-02-18 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/004342 WO2000078961A1 (en) 1999-06-23 2000-02-18 Secreted and transmembrane polypeptides and nucleic acids encoding the same
US0004342 2000-02-18
US0004341 2000-02-18
US0004414 2000-02-22
PCT/US2000/004414 WO2001004311A1 (en) 1999-07-07 2000-02-22 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/005004 WO2000053757A2 (en) 1999-03-08 2000-02-24 Promotion or inhibition of angiogenesis and cardiovascularization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003420475A Division JP2004154140A (ja) 1999-03-08 2003-12-18 血管形成及び心血管新生の促進又は阻害

Publications (2)

Publication Number Publication Date
JP2003531811A JP2003531811A (ja) 2003-10-28
JP2003531811A5 true JP2003531811A5 (enrdf_load_stackoverflow) 2007-04-12

Family

ID=30773423

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000603378A Pending JP2003531811A (ja) 1999-03-08 2000-02-24 血管形成及び心臓血管新生の促進又は阻害
JP2003420475A Pending JP2004154140A (ja) 1999-03-08 2003-12-18 血管形成及び心血管新生の促進又は阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003420475A Pending JP2004154140A (ja) 1999-03-08 2003-12-18 血管形成及び心血管新生の促進又は阻害

Country Status (6)

Country Link
EP (1) EP1159419A1 (enrdf_load_stackoverflow)
JP (2) JP2003531811A (enrdf_load_stackoverflow)
KR (2) KR20010104373A (enrdf_load_stackoverflow)
AU (1) AU768694B2 (enrdf_load_stackoverflow)
CA (1) CA2361849A1 (enrdf_load_stackoverflow)
WO (1) WO2000053757A2 (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590088B1 (en) 1996-07-19 2003-07-08 Human Genome Sciences, Inc. CD33-like protein
US6689607B2 (en) 1997-10-21 2004-02-10 Human Genome Sciences, Inc. Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US6503184B1 (en) 1997-10-21 2003-01-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
KR101012904B1 (ko) 2001-11-16 2011-02-08 제넨테크, 인크. 안지오포이에틴-유사 단백질 3 ａｎｇｐｔｌ3을 함유하는조성물 및 이를 사용하는 방법
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1863340A2 (en) * 2005-03-11 2007-12-12 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US20090142348A1 (en) * 2006-07-28 2009-06-04 Genentech, Inc. Novel Gene Disruptions, Compositions and Methods Relating Thereto
KR20180000337A (ko) 2009-07-14 2018-01-02 노파르티스 아게 중간엽 줄기 세포 분화
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
MA41044A (fr) 2014-10-08 2017-08-15 Novartis Ag Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
CN112837306B (zh) * 2021-02-20 2022-11-22 薛竟宜 基于深度学习和中智理论的冠状动脉病变功能学定量方法
CN116003569A (zh) * 2022-12-07 2023-04-25 诺未科技（北京）有限公司 一种用于治疗多形性胶质母细胞瘤的疫苗
CN117054652B (zh) * 2023-08-04 2024-05-17 南京医科大学 一种用于辅助检测心肌肥厚的生物标志物及其应用
CN117982987B (zh) * 2024-04-03 2024-06-18 四川厚浦生物科技有限公司 一种白细胞过滤材料及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900673A (en) * 1988-03-28 1990-02-13 President And Fellows Of Harvard College Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CN1309833C (zh) * 1994-04-26 2007-04-11 儿童医学中心公司 血管生成抑制素及其在制备药物中的用途
WO1999058660A1 (en) * 1998-05-12 1999-11-18 Human Genome Sciences, Inc. 97 human secreted proteins
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
WO1999055869A1 (en) * 1998-04-27 1999-11-04 Zymogenetics, Inc. Novel polypeptide growth factors and materials and methods for making them
SV1999000069A (es) * 1998-06-02 2000-04-11 Lilly Co Eli Angiopoyetina relacionada con secuencia del gen 3 en la cicatrizacion de la cara ref. x-12261
WO1999067382A2 (en) * 1998-06-24 1999-12-29 Compugen Ltd. Angiopoietin-like growth factor sequences
JP2007222001A (ja) * 1998-11-17 2007-09-06 Sagami Chem Res Center 疎水性ドメインを有するヒトタンパク質及びそれをコードするｄｎａ
JP3695642B2 (ja) * 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
ATE432987T1 (de) * 1998-12-22 2009-06-15 Genentech Inc Verfahren und zusammensetzungen zur hemmung des neoplastischen zellenwachstums

Similar Documents

Publication Publication Date Title
JP4358159B2 (ja) 血管形成及び心臓血管新生の促進又は阻害
AU768694B2 (en) Promotion or inhibition of angiogenesis and cardiovascularization
KR20010084882A (ko) 신생 세포 성장을 억제하기 위한 방법 및 조성물
JP2003531811A5 (enrdf_load_stackoverflow)
JP2012246296A (ja) 血管形成及び心血管疾患の調節に使用する肝細胞成長因子の新規インヒビター
JP2009019032A (ja) 血管形成及び心臓血管新生の促進又は阻害
KR100543857B1 (ko) 혈관신생 및 심혈관형성의 촉진 또는 억제
EP2042597B1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
JP2003524599A (ja) 血管新生と心血管新生の促進又は阻害
KR100678523B1 (ko) Pro840 폴리펩티드 아고니스트 또는 길항제의 확인 방법
EP1734051A2 (en) Composition and methods for the diagnosis of tumours
AU2003259607B2 (en) Promotion or inhibition of angiogenesis and cardiovascularization
HK1128730A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
HK1128730B (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
NZ532803A (en) Promotion or inhibition of angiogenesis and cardiovascularization
ZA200105990B (en) Promotion or inhibition of angiogenesis and cardiovascularization.
NZ540754A (en) Promotion or inhibition of angiogenesis and cardiovascularization
ZA200103707B (en) Promotion or inhibition of angiogenesis and cardio-vascularization.